Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9


PIM kinase inhibitor, AZD1208, inhibits protein translation and induces autophagy in primary chronic lymphocytic leukemia cells.

Cervantes-Gomez F, Stellrecht CM, Ayres ML, Keating MJ, Wierda WG, Gandhi V.

Oncotarget. 2019 Apr 19;10(29):2793-2809. doi: 10.18632/oncotarget.26876. eCollection 2019 Apr 19.


Decrease in total protein level of Bruton's tyrosine kinase during ibrutinib therapy in chronic lymphocytic leukemia lymphocytes.

Cervantes-Gomez F, Kumar Patel V, Bose P, Keating MJ, Gandhi V.

Leukemia. 2016 Aug;30(8):1803-4. doi: 10.1038/leu.2016.129. Epub 2016 May 20. No abstract available.


Combination of Pim kinase inhibitors and Bcl-2 antagonists in chronic lymphocytic leukemia cells.

Cervantes-Gomez F, Lavergne B, Keating MJ, Wierda WG, Gandhi V.

Leuk Lymphoma. 2016 Feb;57(2):436-444. doi: 10.3109/10428194.2015.1063141. Epub 2015 Sep 28.


Pharmacological and Protein Profiling Suggests Venetoclax (ABT-199) as Optimal Partner with Ibrutinib in Chronic Lymphocytic Leukemia.

Cervantes-Gomez F, Lamothe B, Woyach JA, Wierda WG, Keating MJ, Balakrishnan K, Gandhi V.

Clin Cancer Res. 2015 Aug 15;21(16):3705-15. doi: 10.1158/1078-0432.CCR-14-2809. Epub 2015 Mar 31.


Proteasome inhibitor carfilzomib complements ibrutinib's action in chronic lymphocytic leukemia.

Lamothe B, Cervantes-Gomez F, Sivina M, Wierda WG, Keating MJ, Gandhi V.

Blood. 2015 Jan 8;125(2):407-10. doi: 10.1182/blood-2014-07-585364. No abstract available.


Biological effects of the Pim kinase inhibitor, SGI-1776, in multiple myeloma.

Cervantes-Gomez F, Chen LS, Orlowski RZ, Gandhi V.

Clin Lymphoma Myeloma Leuk. 2013 Sep;13 Suppl 2:S317-29. doi: 10.1016/j.clml.2013.05.019. Epub 2013 Aug 27.


ATP analog enhances the actions of a heat shock protein 90 inhibitor in multiple myeloma cells.

Cervantes-Gomez F, Nimmanapalli R, Gandhi V.

J Pharmacol Exp Ther. 2011 Nov;339(2):545-54. doi: 10.1124/jpet.111.184903. Epub 2011 Aug 5.


Transcription inhibition of heat shock proteins: a strategy for combination of 17-allylamino-17-demethoxygeldanamycin and actinomycin d.

Cervantes-Gomez F, Nimmanapalli R, Gandhi V.

Cancer Res. 2009 May 1;69(9):3947-54. doi: 10.1158/0008-5472.CAN-08-4406. Epub 2009 Apr 21.


Multiple myeloma cell killing by depletion of the MET receptor tyrosine kinase.

Stellrecht CM, Phillip CJ, Cervantes-Gomez F, Gandhi V.

Cancer Res. 2007 Oct 15;67(20):9913-20.

Supplemental Content

Loading ...
Support Center